{"id":1057,"count":2,"description":"<p>Losartan, anjiyotensin resept\u00f6r blokeri olarak adland\u0131r\u0131lan bir tansiyon ilac\u0131 etken maddesidir. Damarlar\u0131n daralmas\u0131na yol a\u00e7an anjiyotensin etkisini engelleyerek kan bas\u0131nc\u0131n\u0131n d\u00fc\u015fmesine yard\u0131mc\u0131 olur. Se\u00e7ilmi\u015f kalp yetersizli\u011fi veya tip 2 diyabete ba\u011fl\u0131 b\u00f6brek hastal\u0131\u011f\u0131 durumlar\u0131nda da kullan\u0131labilir.<\/p><h2>Tansiyon d\u00fc\u015fmesi ve takip<\/h2><p>Y\u00fcksek tansiyon her zaman belirti vermez. Bu nedenle ilac\u0131n i\u015fe yaray\u0131p yaramad\u0131\u011f\u0131 yaln\u0131zca ba\u015f a\u011fr\u0131s\u0131 ya da \u00e7arp\u0131nt\u0131n\u0131n de\u011fi\u015fmesine bak\u0131larak belirlenmez; tansiyon \u00f6l\u00e7\u00fcmleri ve sa\u011fl\u0131k ekibinin de\u011ferlendirmesi \u00f6nemlidir. B\u00f6brek i\u015flevi ve kandaki baz\u0131 de\u011ferlerin izlenmesi gerekebilir. Bir tablette losartan\u0131n tek ba\u015f\u0131na bulunmas\u0131yla ba\u015fka bir maddeyle kombinasyon halinde bulunmas\u0131 ayn\u0131 tedavi de\u011fildir.<\/p><h2>G\u00fcvenlik ve birlikte kullan\u0131m<\/h2><p>Ba\u015f d\u00f6nmesi, halsizlik veya bulant\u0131 g\u00f6r\u00fclebilir. Susuz kalmaya yol a\u00e7an kusma veya ishal s\u0131ras\u0131nda sa\u011fl\u0131k ekibinin \u00f6nerisi al\u0131nmal\u0131d\u0131r. Potasyum i\u00e7eren takviyeler ve tuz ikameleri, baz\u0131 idrar s\u00f6kt\u00fcr\u00fcc\u00fcler ve ibuprofen gibi a\u011fr\u0131 kesiciler birlikte kullan\u0131m a\u00e7\u0131s\u0131ndan kontrol edilir. Gebelikte kullan\u0131m i\u00e7in \u00f6zel g\u00fcvenlik uyar\u0131lar\u0131 vard\u0131r; gebelik veya gebelik plan\u0131 doktorla payla\u015f\u0131lmal\u0131d\u0131r. Losartan acil y\u00fcksek tansiyon durumunu ki\u015fisel doz art\u0131r\u0131m\u0131yla y\u00f6netme arac\u0131 de\u011fildir. A\u015fa\u011f\u0131daki \u00fcr\u00fcn kay\u0131tlar\u0131, ki\u015finin tedavisini de\u011fi\u015ftirmek veya farkl\u0131 tansiyon ila\u00e7lar\u0131n\u0131 e\u015fde\u011fer saymak i\u00e7in kullan\u0131lamaz. Doz ve kullan\u0131m s\u00fcresi re\u00e7ete ile \u00fcr\u00fcne \u00f6zg\u00fc talimata g\u00f6re belirlenir.<\/p><h2>Kaynaklar ve kapsam<\/h2><ul><li><a href=\"https:\/\/www.nhs.uk\/medicines\/losartan\/\" target=\"_blank\" rel=\"noopener\">NHS: Losartan<\/a> (Birle\u015fik Krall\u0131k) \u2014 Genel kullan\u0131m, takip, gebelik ve etkile\u015fim \u00e7er\u00e7evesi.<\/li><li><a href=\"https:\/\/medlineplus.gov\/druginfo\/meds\/a695008.html\" target=\"_blank\" rel=\"noopener\">MedlinePlus: Losartan<\/a> (ABD) \u2014 Anjiyotensin resept\u00f6r blokeri mekanizmas\u0131 ve g\u00fcvenlik.<\/li><\/ul><p><small>Kaynak kontrol\u00fc: <time datetime=\"2026-10-11\">11 Ekim 2026<\/time>. Kaynak do\u011frulamas\u0131 klinik uzman incelemesi de\u011fildir. \u0130\u00e7erik, kaynaklara dayal\u0131 yapay zek\u00e2 destekli genel bilgi \u00f6zetidir.<\/small><\/p>","link":"https:\/\/www.ortaakarsu.net\/?ism_etken_madde=losartan-potasyum","name":"Losartan Potasyum","slug":"losartan-potasyum","taxonomy":"ism_etken_madde","meta":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/ism_etken_madde\/1057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/ism_etken_madde"}],"about":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/taxonomies\/ism_etken_madde"}],"wp:post_type":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=%2Fwp%2Fv2%2Fism_drug&ism_etken_madde=1057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}